Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...

MENLO PARK, Calif., Feb. 1, 2024 /PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international, ...

Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology. MENLO PARK, Calif., Dec. 7, 2023 ...

Acutus Medical Inc AFIB announced a realignment of resources and corporate restructuring to become a contract manufacturing business that could generate positive cash flow over the next several years.

HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life "These are excellent results for ...

Cortex's fully integrated solution will include advanced diagnostic and therapeutic pulsed field ablation catheters supported by innovative mapping technology. Cortex brings together expert teams with ...